Gardner Medical Instruments Receives FDA Class I Registration for Ventubation Airway Management System
Gardner Medical Instruments, LLC has announced that it has received U.S. Food and Drug Administration (FDA) Class I registration for its Ventubation™ System, a novel airway management platform designed to support safer, faster and more controlled endotracheal intubation. The system consists of the IntroGard® introducer and SupraVent™ supraglottic airway, which are designed to work together to maintain ventilation while facilitating placement of an endotracheal tube.
The FDA registration represents an important regulatory milestone for Gardner Medical Instruments as the company prepares to bring its airway management technology to the U.S. market. FDA Class I devices are generally subject to the lowest level of regulatory controls among medical devices, reflecting products for which established safety profiles and general controls are considered appropriate. Registration and listing are foundational requirements associated with lawful commercial distribution of applicable medical devices in the United States.
The Ventubation System is also gaining recognition within the emergency medical services community. The technology has been nominated for the EMS World EXPO Innovation Award, which recognizes products identified as potentially significant innovations in emergency medical services. Finalists are evaluated by an independent panel of judges from the EMS World Editorial Advisory Board, with one-on-one product demonstrations conducted during the annual EMS Expo.
The EMS World EXPO is scheduled for September 28 through October 2, with Innovation Award winners expected to be announced in the fall.
A New Approach to Airway Management
Airway management is a critical component of emergency and acute medical care. Endotracheal intubation may be required when patients cannot adequately maintain or protect their airway or require mechanical ventilation. The procedure can be particularly challenging in emergency situations, where providers may have limited time and where patient conditions can change rapidly.
Gardner Medical Instruments developed the Ventubation System around the concept of maintaining ventilation during the intubation process.
The company describes the system as a new generation of airway management technology intended to address some of the challenges associated with conventional intubation. Its design is intended to provide airway control while allowing ventilation to continue during placement of the endotracheal tube.
According to Gardner Medical Instruments, the platform is designed to help reduce intubation-induced hypoxia, a condition in which oxygen levels in the blood can fall during airway management. Maintaining adequate oxygenation is an important consideration during intubation, particularly for patients who are already experiencing respiratory compromise.
The Ventubation System incorporates two primary components: the SupraVent supraglottic airway and the IntroGard introducer.
SupraVent Provides an Airway and Intubation Conduit
The SupraVent is a supraglottic airway device designed to establish and maintain an airway while also providing a dedicated pathway for endotracheal intubation.
Supraglottic airway devices are positioned above the vocal cords and are commonly used to establish ventilation without initially placing an endotracheal tube into the trachea. The SupraVent takes this concept further by incorporating a conduit intended to facilitate subsequent endotracheal tube placement.
The company says the design eliminates the need for a rigid laryngoscope during the intubation process. A conventional rigid laryngoscope is commonly used to visualize the airway and facilitate passage of an endotracheal tube.
By providing an alternative pathway for tube placement, the SupraVent is intended to simplify the procedure while allowing providers to maintain ventilation.
Continuous ventilation during intubation is a central feature of the Ventubation approach. Conventional airway management can involve periods in which ventilation is interrupted while a provider attempts to visualize the airway and place the endotracheal tube. Gardner Medical Instruments designed its system to address this aspect of the procedure.
The company believes that maintaining ventilation during intubation could help support oxygenation while providers work to establish a definitive airway.
IntroGard Designed to Support Endotracheal Tube Placement
The second major component of the Ventubation System is the IntroGard introducer.
IntroGard is designed to securely couple to a standard endotracheal tube and guide the tube toward the trachea. According to Gardner Medical Instruments, the introducer has an anatomical design intended to support smooth and atraumatic advancement through the airway.
The objective is to provide providers with a controlled pathway for advancing the endotracheal tube and potentially support first-pass success.
First-pass success refers to successful placement of an endotracheal tube on the initial attempt. Achieving successful intubation without repeated attempts is an important consideration in airway management because multiple attempts can increase procedural complexity and may contribute to complications.
The company has designed IntroGard to work in conjunction with SupraVent, creating an integrated system rather than relying on a series of unrelated airway devices.
Focus on Continuous Ventilation
A central element of Gardner Medical Instruments’ technology is the ability to maintain ventilation while intubation is being performed.
Intubation can be a high-pressure procedure, particularly in emergency medical settings. Patients may already have compromised oxygenation, and delays in securing an airway can create additional challenges for clinical teams.
The Ventubation System is intended to address this issue by establishing an airway through the SupraVent while providing a conduit for endotracheal tube placement. The system is designed to allow ventilation to continue during the intubation process.
Gardner Medical Instruments believes that this approach could provide providers with greater control during airway management while reducing the need to interrupt ventilation as they work to secure the airway.
The company is positioning the technology for use in settings where reliable airway control is essential, although the specific clinical applications and appropriate use cases will depend on the device’s labeling, instructions for use and applicable clinical protocols.
FDA Class I Registration Marks Regulatory Milestone
The FDA Class I registration represents an important development in the commercial progression of the Ventubation System.
Medical devices in the United States are classified into three regulatory categories—Class I, Class II and Class III—based on factors including risk and the controls needed to provide reasonable assurance of safety and effectiveness. Class I devices generally face the lowest level of regulatory controls.
Gardner Medical Instruments said the Class I registration establishes a foundational regulatory status for the Ventubation System and supports its lawful sale and distribution in the United States.
The regulatory milestone provides the company with an opportunity to advance commercialization while continuing to build awareness of the technology among emergency medical services and other healthcare professionals.
FDA registration itself should not be interpreted as an endorsement of the device’s clinical performance or as evidence that the system eliminates the risks associated with intubation. Airway management remains a procedure requiring appropriate training, clinical judgment and adherence to applicable protocols.
Recognition From EMS World EXPO
In addition to the FDA milestone, the Ventubation System has been nominated for the EMS World EXPO Innovation Award.
The award program is designed to recognize new technologies and products that could contribute to innovation within emergency medical services. Finalists are reviewed by an independent panel of judges drawn from the EMS World Editorial Advisory Board.
The evaluation process includes individual demonstrations of nominated technologies during the annual EMS Expo. This provides an opportunity for emergency medical professionals and industry representatives to examine the technology and understand its intended application.
The 2026 EMS World EXPO is scheduled for September 28 through October 2, with Innovation Award winners expected to be announced later in the fall.
The nomination places the Ventubation System among technologies receiving attention from the EMS community as Gardner Medical Instruments works to introduce its airway management platform.
Addressing Longstanding Airway Management Challenges
Glenn Gardner, MD, Founder and President of Gardner Medical Instruments, said the company developed the system in response to what he views as longstanding challenges in airway management.
“Airway management is often one of the most high-stakes moments in clinical care, yet the tools we rely on have been static for 60 years,” Gardner said.
He explained that the Ventubation platform was designed around the goal of maintaining continuous ventilation while an endotracheal tube is placed.
“The Ventubation airway management platform was built from a clear necessity: to take the risk and stress out of airway management by maintaining continuous ventilation during intubation,” Gardner said.
According to Gardner, the company’s objective is to provide clinicians with greater confidence and control during the procedure while supporting first-pass success.
The statement reflects the company’s broader positioning of Ventubation as a platform intended to modernize elements of a procedure that has traditionally relied on established airway management tools and techniques.
Potential Role Across Emergency Care
Airway management is relevant across a range of healthcare environments, including emergency medical services, emergency departments, intensive care units and other settings where advanced airway support may be required.
The Ventubation System’s combination of a supraglottic airway and intubation introducer is designed to provide a structured approach to securing an endotracheal airway.
The system’s ability to maintain ventilation during intubation is a central differentiating feature identified by Gardner Medical Instruments. The company believes that the approach may help providers manage the transition from initial airway establishment to definitive endotracheal intubation.
The potential clinical value of the system will depend on appropriate use, provider training and real-world clinical experience. As with all airway management technologies, patient selection and clinical circumstances remain important considerations.
Moving Toward Broader Adoption
With FDA Class I registration and an EMS World EXPO Innovation Award nomination, Gardner Medical Instruments is entering the next phase of development for the Ventubation System.
The company is seeking to establish its technology as an alternative approach to airway management by combining the functions of airway maintenance, ventilation and endotracheal tube guidance within an integrated platform.
The SupraVent is designed to establish and maintain the airway and provide a conduit for intubation, while IntroGard is designed to guide a standard endotracheal tube toward the trachea. Together, the components are intended to support continuous ventilation throughout the intubation process.
Gardner Medical Instruments said the overarching goal is to provide clinicians with a more controlled airway management process and support successful intubation while reducing the risk associated with interruptions in ventilation.
The company’s FDA Class I registration provides a regulatory foundation for commercial distribution in the United States, while the EMS World EXPO nomination provides an additional opportunity to demonstrate the technology to emergency medical professionals.
As Gardner Medical Instruments continues its commercialization efforts, the Ventubation System represents the company’s approach to addressing persistent challenges in airway management through a platform focused on continuous ventilation, controlled tube advancement and first-pass intubation.
About Gardner Medical Instruments
Gardner Medical Instruments, LLC is committed to developing technologies that simplify airway management by providing continuous ventilation and reducing the risks of hypoxia and airway injury. We are committed to designing procedures and tools that improve patient safety and enhance clinical confidence – because every second counts.